LB Pharmaceuticals Inc
LBRX
$29.66
-$1.75-5.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,205.89% | 954.37% | -- | -80.28% | -61.18% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 437.55% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 2,449.05% | -- | -- | -- |
| Total Current Assets | -- | 968.01% | -- | -- | -- |
|
|
|||||
| Total Current Assets | -- | 968.01% | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -10.22% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 54.62% | -- | -- | -- |
| Total Assets | -- | 833.18% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -- | -8.32% | -- | -- | -- |
| Total Accrued Expenses | -- | -13.52% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 49.90% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -- | -8.23% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -- | -8.23% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -11.72% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -46.37% | -- | -- | -- |
| Total Liabilities | -- | -15.94% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | -- | 4,359.20% | -- | -- | -- |
| Retained Earnings | -- | -24.16% | -- | -- | -- |
| Treasury Stock & Other | -- | 51.35% | -- | -- | -- |
| Total Common Equity | 500.50% | 418.66% | -- | -105.91% | -87.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 500.50% | 418.66% | -- | -105.91% | -87.44% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,821.81% | 1,429.10% | -- | -83.72% | -69.12% |
|
|
|||||